Fengna Chu

1.3k total citations · 1 hit paper
28 papers, 959 citations indexed

About

Fengna Chu is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Fengna Chu has authored 28 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Physiology and 8 papers in Immunology. Recurrent topics in Fengna Chu's work include Peripheral Neuropathies and Disorders (6 papers), Alzheimer's disease research and treatments (6 papers) and Tryptophan and brain disorders (6 papers). Fengna Chu is often cited by papers focused on Peripheral Neuropathies and Disorders (6 papers), Alzheimer's disease research and treatments (6 papers) and Tryptophan and brain disorders (6 papers). Fengna Chu collaborates with scholars based in China, Sweden and Mexico. Fengna Chu's co-authors include Jie Zhu, Mingchao Shi, Donghui Shen, Chao Zheng, Li Cui, Feiqi Zhu, Tao Jin, Xiangyu Zheng, Yue Lang and Jingtao Chen and has published in prestigious journals such as Experimental Neurology, Clinica Chimica Acta and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Fengna Chu

28 papers receiving 947 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab

2022 184 citations Mingchao Shi, Fengna Chu et al. Frontiers in Aging Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fengna Chu China	13	366	255	237	232	141	28	959
Mingchao Shi China	12	245 0.7×	195 0.8×	185 0.8×	135 0.6×	115 0.8×	37	864
Francesca La Rosa Italy	18	746 2.0×	318 1.2×	311 1.3×	300 1.3×	90 0.6×	40	1.3k
Yuqing Yan China	18	547 1.5×	133 0.5×	159 0.7×	107 0.5×	138 1.0×	48	1.1k
Mark Watling Italy	16	220 0.6×	426 1.7×	138 0.6×	249 1.1×	47 0.3×	29	982
Massimo Barbierato Italy	17	170 0.5×	125 0.5×	211 0.9×	138 0.6×	66 0.5×	28	714
Ajaib S. Paintlia United States	21	510 1.4×	195 0.8×	262 1.1×	327 1.4×	175 1.2×	29	1.3k
Long Wang China	20	393 1.1×	113 0.4×	88 0.4×	90 0.4×	70 0.5×	74	1.0k
Manjeet K. Paintlia United States	24	573 1.6×	211 0.8×	263 1.1×	421 1.8×	192 1.4×	35	1.6k
Jun Tan China	16	379 1.0×	169 0.7×	231 1.0×	157 0.7×	29 0.2×	28	914
Junwei Zeng China	18	439 1.2×	154 0.6×	181 0.8×	253 1.1×	36 0.3×	45	973

Countries citing papers authored by Fengna Chu

Since Specialization

Citations

This map shows the geographic impact of Fengna Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengna Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengna Chu more than expected).

Fields of papers citing papers by Fengna Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengna Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengna Chu. The network helps show where Fengna Chu may publish in the future.

Co-authorship network of co-authors of Fengna Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengna Chu. A scholar is included among the top collaborators of Fengna Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengna Chu. Fengna Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chu, Fengna, et al.. (2025). Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two. Autoimmunity Reviews. 24(4). 103761–103761. 2 indexed citations

Shi, Mingchao, Fengna Chu, & Jie Zhu. (2025). Stem cells therapy in neurodegenerative and neuroimmune diseases: Current status of treatments and future prospects. Pharmacological Research. 221. 107960–107960. 1 indexed citations

Chu, Fengna, et al.. (2023). Discrepancy in clinical and laboratory profiles of NMOSD patients between AQP4 antibody positive and negative: can NMOSD be diagnosed without AQP4 antibody?. Clinical & Experimental Immunology. 213(3). 363–370. 6 indexed citations

Balleza‐Tapia, Hugo, Fengna Chu, Gefei Chen, et al.. (2023). Low dose of levetiracetam counteracts amyloid β-induced alterations of hippocampal gamma oscillations by restoring fast-spiking interneuron activity. Experimental Neurology. 369. 114545–114545. 4 indexed citations

Zheng, Chao, Lingling Liu, Caiyun Liu, et al.. (2023). Alleviation of experimental autoimmune encephalomyelitis by transferring low RelB expression tolerogenic dendritic cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166934–166934. 2 indexed citations

Shi, Mingchao, Fengna Chu, Feiqi Zhu, & Jie Zhu. (2022). Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab. Frontiers in Aging Neuroscience. 14. 870517–870517. 184 indexed citations breakdown →

Shi, Mingchao, Fengna Chu, Tao Jin, & Jie Zhu. (2022). Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD. CNS Neuroscience & Therapeutics. 28(7). 981–991. 24 indexed citations

Shi, Mingchao, Chunrong Li, Xiaoping Tian, Fengna Chu, & Jie Zhu. (2021). Can Control Infections Slow Down the Progression of Alzheimer’s Disease? Talking About the Role of Infections in Alzheimer’s Disease. Frontiers in Aging Neuroscience. 13. 685863–685863. 10 indexed citations

Shi, Mingchao, et al.. (2021). Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer’s Disease: Are Immunotherapies Effective or Off-Target?. The Neuroscientist. 28(3). 254–270. 12 indexed citations

10.

Liu, Caiyun, Mingchao Shi, Mingqin Zhu, et al.. (2021). Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges. Autoimmunity Reviews. 21(1). 102921–102921. 12 indexed citations

11.

Shen, Donghui, Fengna Chu, Yue Lang, et al.. (2021). Nuclear factor kappa B inhibitor suppresses experimental autoimmune neuritis in mice via declining macrophages polarization to M1 type. Clinical & Experimental Immunology. 206(1). 110–117. 11 indexed citations

12.

Chu, Fengna, Mingyu Shi, Yue Lang, et al.. (2021). Adoptive transfer of immunomodulatory M2 macrophages suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice via blockading NF-κB pathway. Clinical & Experimental Immunology. 204(2). 199–211. 19 indexed citations

13.

Zhang, Kejia, Fengna Chu, Chao Wang, Mingchao Shi, & Yi Yang. (2021). Progressive Stroke Caused by Neurosyphilis With Concentric Enhancement in the Internal Cerebral Artery on High-Resolution Magnetic Resonance Imaging: A Case Report. Frontiers in Neurology. 12. 675083–675083. 8 indexed citations

14.

Zhu, Feiqi, Chunrong Li, Fengna Chu, Xiaoping Tian, & Jie Zhu. (2020). Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer’s Disease. Frontiers in Aging Neuroscience. 12. 544235–544235. 43 indexed citations

15.

Zheng, Chao, Jingtao Chen, Fengna Chu, Jie Zhu, & Tao Jin. (2020). Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis. Frontiers in Molecular Neuroscience. 12. 314–314. 98 indexed citations

16.

Shen, Donghui, Fengna Chu, Yue Lang, et al.. (2018). Beneficial or Harmful Role of Macrophages in Guillain-Barré Syndrome and Experimental Autoimmune Neuritis. Mediators of Inflammation. 2018. 1–10. 30 indexed citations

17.

Chu, Fengna, Mingchao Shi, Chao Zheng, et al.. (2018). The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 318. 1–7. 241 indexed citations

18.

Lang, Yue, et al.. (2018). Mass spectrometry-based metabolomics for tuberculosis meningitis. Clinica Chimica Acta. 483. 57–63. 13 indexed citations

19.

Lv, Yudan, Zan Wang, Fengna Chu, Chang Liu, & Hongmei Meng. (2016). Epilepsia partialis continua present with shoulder joint-trunk-hip joint rhythmic clonic seizure: a case report. Neuropsychiatric Disease and Treatment. Volume 12. 2363–2366. 3 indexed citations

20.

Chu, Fengna, et al.. (2014). The relationship between interictal epileptic discharges and sleep cycle of 240 epilepsy patients. Chin J Neurol. 47(1). 35–38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact